Dose container
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a front perspective view of a dose container showing my new design;
FIG. 2 is a rear elevational view thereof;
FIG. 3 is a side elevational view thereof;
FIG. 4 is a bottom plan view thereof.
Referenced Cited
Patent History
Patent number: D289200
Type: Grant
Filed: Aug 22, 1984
Date of Patent: Apr 7, 1987
Assignee: Glaxo Group Limited (London)
Inventor: Robert E. Newell (Pinner)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella M. Reid
Law Firm: McAulay, Fields, Fisher, Goldstein & Nissen
Application Number: 6/643,287
Type: Grant
Filed: Aug 22, 1984
Date of Patent: Apr 7, 1987
Assignee: Glaxo Group Limited (London)
Inventor: Robert E. Newell (Pinner)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella M. Reid
Law Firm: McAulay, Fields, Fisher, Goldstein & Nissen
Application Number: 6/643,287
Classifications
Current U.S. Class:
D24/56;
D/9341